AZD 3241 是一种不可逆的、选择性的、口服具有活力的髓过氧化物酶 (myeloperoxidase) 抑制剂，IC50=630 nM，可用于研究大脑神经退行性疾病。

Verdiperstat (AZD3241) is a selective, irreversible and orally active myeloperoxidase inhibitor, with an IC50 of 630 nM, and can be used in the research of neurodegenerative brain disorders.

Verdiperstat (AZD3241) is a myeloperoxidase (MPO) inhibitor, with an IC50 of 630 nM, and is used in the research of neurodegenerative brain disorders[1]. Verdiperstat (AZD3241) selectively and irreversibly inhibits myeloperoxidase, and may involves reduction of oxidative stress leading to reduction of sustained neuroinflammation.

890655-80-8

C11H15N3O2S

253.32

AZD3241;AZD 3241

DMSO:150 mg/mL (592.14 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years